C14orf166 overexpression correlates with tumor progression and poor prognosis of breast cancer

被引:0
|
作者
Tuck-yun Cheang
Hong-yan Zhou
Wei Chen
Bing Zhang
Liangshuai Liu
Jianyong Yang
Shenming Wang
Heping Li
机构
[1] The First Affiliated Hospital of Sun Yat-sen University,Department of Thyroid and Breast Surgery
[2] The First Affiliated Hospital of Sun Yat-sen University,Department of Neurological Intensive Care Unit
[3] The First Affiliated Hospital of Sun Yat-sen University,Department of Medical Imaging
[4] The First Affiliated Hospital of Sun Yat-sen University,Department of Medical Oncology
关键词
Breast cancer; C14orf166; Prognostic factor; Cell proliferation;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [21] C14orf166 is a high-risk biomarker for bladder cancer and promotes bladder cancer cell proliferation
    Chen, Mingkun
    Ye, Yunlin
    Zou, Baojia
    Guo, Suping
    Zhou, Fangjian
    Lu, Keshi
    Liu, Jianye
    Xu, Zhenzhou
    Han, Hui
    Liu, Zhuowei
    Li, Yonghong
    Yao, Kai
    Liu, Cundong
    Qin, Zike
    JOURNAL OF TRANSLATIONAL MEDICINE, 2016, 14
  • [22] Overexpression of EIF5A2 correlates with tumor progression and predicts poor prognosis in cervical cancer
    Li, Hu
    Xu, Yan
    Yang, Li
    He, Lei
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2016, 9 (05): : 5493 - 5498
  • [23] High MicroRNA-370 Expression Correlates with Tumor Progression and Poor Prognosis in Breast Cancer
    Sim, Jongmin
    Ahn, Hyein
    Abdul, Rehman
    Kim, Hyunsung
    Yi, Ki-jong
    Chung, Yu-min
    Chung, Min Sung
    Paik, Seung Sam
    Song, Young Soo
    Jang, Kiseok
    JOURNAL OF BREAST CANCER, 2015, 18 (04) : 323 - 328
  • [24] Overexpression of nanog predicts tumor progression and poor prognosis in colorectal cancer
    Meng, Hui-Min
    Zheng, Ping
    Wang, Xiao-Yan
    Liu, Chao
    Sui, Hong-Mei
    Wu, Shao-Jie
    Zhou, Jun
    Ding, Yan-Qing
    Li, Jian-Ming
    CANCER BIOLOGY & THERAPY, 2010, 9 (04) : 295 - 302
  • [25] Overexpression of thymosin β10 correlates with disease progression and poor prognosis in bladder cancer
    Wang, Bingwei
    Wang, Zhenwei
    Zhang, Tao
    Yang, Guosheng
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2019, 18 (05) : 3759 - 3766
  • [26] Overexpression of RhoGDI2 Correlates with Tumor Progression and Poor Prognosis in Colorectal Carcinoma
    Li, Xianzheng
    Wang, Jianmei
    Zhang, Xiaojing
    Zeng, Yuanfeng
    Liang, Li
    Ding, Yanqing
    ANNALS OF SURGICAL ONCOLOGY, 2012, 19 (01) : 145 - 153
  • [27] Overexpression of SPAG9 correlates with poor prognosis and tumor progression in hepatocellular carcinoma
    Xie, Chengyao
    Fu, Lin
    Liu, Nan
    Li, Qingchang
    TUMOR BIOLOGY, 2014, 35 (08) : 7685 - 7691
  • [28] Overexpression of RAB34 correlates with poor prognosis and tumor progression in hepatocellular carcinoma
    Wu, Jianwu
    Lu, Yijie
    Qin, Ancheng
    Qiao, Zhiming
    Jiang, Xinwei
    ONCOLOGY REPORTS, 2017, 38 (05) : 2967 - 2974
  • [29] Overexpression of RhoGDI2 Correlates with Tumor Progression and Poor Prognosis in Colorectal Carcinoma
    Xianzheng Li
    Jianmei Wang
    Xiaojing Zhang
    Yuanfeng Zeng
    Li Liang
    Yanqing Ding
    Annals of Surgical Oncology, 2012, 19 : 145 - 153
  • [30] Overexpression of HDAC9 is associated with poor prognosis and tumor progression of breast cancer in Chinese females
    Huang, Yixiang
    Jian, Wei
    Zhao, Junyong
    Wang, Gang
    ONCOTARGETS AND THERAPY, 2018, 11 : 2177 - 2184